1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pelvic Floor Electrical Stimulation Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Market Introduction
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pelvic Floor Electrical Stimulation Devices Market Analysis and Forecasts, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume Projections (Units)
5. Key Insights
5.1. Technological Advancements
5.2. Pricing Analysis
5.3. Regulatory Scenario, by Key Countries
5.4. Disease Prevalence & Incidence Rate globally with key countries
5.5. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
5.6. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6. Global Pelvic Floor Electrical Stimulation Devices Market Analysis and Forecasts, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Product Type, 2018–2030
6.3.1. Mobile
6.3.2. Fixed
6.4. Market Attractiveness Analysis, by Product Type
7. Global Pelvic Floor Electrical Stimulation Devices Market Analysis and Forecasts, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast by Application, 2018–2030
7.3.1. Urinary Incontinence Treatment
7.3.2. Neurodegenerative Diseases
7.3.3. Sexual Dysfunction
7.3.4. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Pelvic Floor Electrical Stimulation Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2018–2030
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Home Care Settings
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Pelvic Floor Electrical Stimulation Devices Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value & Volume Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Pelvic Floor Electrical Stimulation Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Product Type, 2018–2030
10.2.1. Mobile
10.2.2. Fixed
10.3. Market Value Forecast, by Application, 2018–2030
10.3.1. Urinary Incontinence Treatment
10.3.2. Neurodegenerative Diseases
10.3.3. Sexual Dysfunction
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2018–2030
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Home Care Settings
10.4.4. Others
10.5. Market Value Forecast, by Country, 2018–2030
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Pelvic Floor Electrical Stimulation Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Product Type, 2018–2030
11.2.1. Mobile
11.2.2. Fixed
11.3. Market Value Forecast, by Application, 2018–2030
11.3.1. Urinary Incontinence Treatment
11.3.2. Neurodegenerative Diseases
11.3.3. Sexual Dysfunction
11.3.4. Others
11.4. Market Value Forecast by End-user, 2018–2030
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Home Care Settings
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2018–2030
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Pelvic Floor Electrical Stimulation Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Product Type, 2018–2030
12.2.1. Mobile
12.2.2. Fixed
12.3. Market Value Forecast, by Application, 2018–2030
12.3.1. Urinary Incontinence Treatment
12.3.2. Neurodegenerative Diseases
12.3.3. Sexual Dysfunction
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2018–2030
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Home Care Settings
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2018–2030
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Pelvic Floor Electrical Stimulation Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Product Type, 2018–2030
13.2.1. Mobile
13.2.2. Fixed
13.3. Market Value Forecast, by Application, 2018–2030
13.3.1. Urinary Incontinence Treatment
13.3.2. Neurodegenerative Diseases
13.3.3. Sexual Dysfunction
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2018–2030
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Home Care Settings
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2018–2030
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Pelvic Floor Electrical Stimulation Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Product Type, 2018–2030
14.2.1. Mobile
14.2.2. Fixed
14.3. Market Value Forecast, by Application, 2018–2030
14.3.1. Urinary Incontinence Treatment
14.3.2. Neurodegenerative Diseases
14.3.3. Sexual Dysfunction
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2018–2030
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Home Care Settings
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2018–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share/Position Analysis, by Company, 2019
15.3. Company Profiles
15.3.1. Atlantic Therapeutics
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Company Financials
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. Utah Medical Products, Inc.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. The Prometheus Group
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Company Financials
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. Shenzhen XFT Medical Limited
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Company Financials
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. KayCo 2 Ltd.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Company Financials
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. Zynex Medical
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Company Financials
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. TensCare Ltd.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Company Financials
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. Laborie, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Company Financials
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. Verity Medical Ltd
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Company Financials
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
15.3.10. Tic Medizintechnik GmbH
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Company Financials
15.3.10.3. Growth Strategies
15.3.10.4. SWOT Analysis
15.3.11. InControl Medical Limited
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Company Financials
15.3.11.3. Growth Strategies
15.3.11.4. SWOT Analysis